William C. Chapman

William C. Chapman, MD, FACS

  • Liver, Pancreas & Gastrointestinal Surgery
  • Transplant Surgery
Video Profile

Sees Patients For

Surgical treatment of complex hepatobiliary conditions, image-guided liver surgery, gallstone pathogenesis and prevention, hepatic transplant immunosuppression, hepatic surgery, bile duct surgery, liver surgery, bile duct surgery, surgery for portal hypertension, radiofrequency ablation (RFA) of liver tumors, cryoablation, hepatic artery infusion (HAI) pumps, liver transplant in adults, liver transplant in children, living donor, living adult related donor, adult to adult liver doner, live doner transplant

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital
  • St. Louis Children's Hospital
  • VA Medical Center - St. Louis

Board Certifications

  • Critical Care
  • General Surgery

Academic Title(s)

Professor, Surgery
Eugene M. Bricker Chair of Surgery
Chief, Division of General Surgery
Chief, Abdominal Transplantation Section


  • English



1992 Hepatobiliary Surgery and Liver Transplantation, Kings College Hospital, London, England

Chief Residency

1991 General Surgery, Vanderbilt University Hospital, Nashville, Tennessee


1989 Hepatobiliary Research, Vanderbilt University Medical Center, Nashville, Tennesee


1987 General Surgery, Vanderbilt University Hospital, Nashville, Tennessee

Medical Degree

1984 Medical University of South Carolina, Charleston, South Carolina


1980 Chemistry, University of North Carolina, Chapel Hill, North Carolina

Research Interests

Liver-lung interactions following liver injury, Image-guided liver surgery, Transcriptional regulation of hepatocellular carcinoma, Surgical Treatment of complex hepatobiliary problems, Hepatic transplant immunosuppression, Gallstone pathogenesis and prevention

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.